MEDICO REMEDIES Financial Statement Analysis
|
||
|
The Revenues of MEDICO REMEDIES have increased by 36.73% YoY .
The Earnings Per Share (EPS) of MEDICO REMEDIES has increased by 29.51 % YoY. |
||
MEDICO REMEDIES Last 5 Annual Financial Results
[BOM: 540937|NSE : MEDICO]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹206 Cr | ₹151 Cr | ₹145 Cr | ₹140 Cr | ₹121 Cr |
| Expenses | ₹189 Cr | ₹137 Cr | ₹132 Cr | ₹131 Cr | ₹114 Cr |
| Operating Profit (Excl OI) | ₹17 Cr | ₹14 Cr | ₹13 Cr | ₹9.48 Cr | ₹7.34 Cr |
| Other Income | ₹5.93 Cr | ₹3.27 Cr | ₹2.13 Cr | ₹4.09 Cr | ₹2.03 Cr |
| Interest | ₹1.81 Cr | ₹1.16 Cr | ₹0.82 Cr | ₹0.75 Cr | ₹0.66 Cr |
| Depreciation | ₹3.10 Cr | ₹3.03 Cr | ₹2.88 Cr | ₹2.72 Cr | ₹2.22 Cr |
| Profit Before Tax | ₹18 Cr | ₹14 Cr | ₹11 Cr | ₹10 Cr | ₹6.48 Cr |
| Profit After Tax | ₹13 Cr | ₹10 Cr | ₹8.29 Cr | ₹7.24 Cr | ₹4.81 Cr |
| Earnings Per Share (Rs) | ₹1.58 | ₹1.22 | ₹1.00 | ₹0.87 | ₹2.90 |
| PAT Margin (%) | 6.35 | 6.69 | 5.72 | 5.16 | 3.98 |
| ROE(%) | 19.02 | 17.58 | 17.23 | 18.01 | 13.94 |
| ROCE(%) | 23.28 | 21.65 | 21.90 | 21.88 | 15.09 |
| Total Debt/Equity(x) | 0.25 | 0.22 | 0.13 | 0.18 | 0.29 |
Key Financials |
||
| Market Cap | : | ₹ 181.9 Cr |
| Revenue (TTM) | : | ₹ 237.5 Cr |
| Net Profit(TTM) | : | ₹ 13.8 Cr |
| EPS (TTM) | : | ₹ 1.7 |
| P/E (TTM) | : | 13.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MEDICO REMEDIES | -0.8% | -38.3% | -56% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.1% | -5% | 5.4% |
| DIVIS LABORATORIES | -1.7% | 0.2% | 39.5% |
| TORRENT PHARMACEUTICALS | -2.5% | -5.5% | 30.2% |
| CIPLA | 0.9% | -2.6% | -14.6% |
| DR REDDYS LABORATORIES | 0.1% | 7.6% | -3.5% |
| MANKIND PHARMA | -5.2% | 1.2% | -4.2% |
| LUPIN | 0.5% | -4.5% | -0% |
| ZYDUS LIFESCIENCES | -1.3% | 1.8% | 14.8% |
MEDICO REMEDIES Revenues
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 36.73 % |
| 5 Yr CAGR | 14.27 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹206 Cr | 36.73 | |
| Mar2025 | ₹151 Cr | 4.15 | |
| Mar2024 | ₹145 Cr | 3.19 | |
| Mar2023 | ₹140 Cr | 16.04 | |
| Mar2022 | ₹121 Cr | - | |
MEDICO REMEDIES Operating Profit
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 18.07 % |
| 5 Yr CAGR | 23.43 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 Cr | 18.07 | |
| Mar2025 | ₹14 Cr | 11.71 | |
| Mar2024 | ₹13 Cr | 36.16 | |
| Mar2023 | ₹9.48 Cr | 29.26 | |
| Mar2022 | ₹7.34 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -13.61 % |
| 5 Yr CAGR | 8.02 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 8.25% | -13.61 | |
| Mar2025 | 9.55% | 7.18 | |
| Mar2024 | 8.91% | 32.00 | |
| Mar2023 | 6.75% | 11.39 | |
| Mar2022 | 6.06% | - | |
MEDICO REMEDIES Profit After Tax
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 29.94 % |
| 5 Yr CAGR | 28.49 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹13 Cr | 29.94 | |
| Mar2025 | ₹10 Cr | 21.73 | |
| Mar2024 | ₹8.29 Cr | 14.48 | |
| Mar2023 | ₹7.24 Cr | 50.50 | |
| Mar2022 | ₹4.81 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -5.08 % |
| 5 Yr CAGR | 12.39 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 6.35 % | -5.08 | |
| Mar2025 | 6.69 % | 16.96 | |
| Mar2024 | 5.72 % | 10.85 | |
| Mar2023 | 5.16 % | 29.65 | |
| Mar2022 | 3.98 % | - | |
MEDICO REMEDIES Earnings Per Share (EPS)
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 29.51 % |
| 5 Yr CAGR | -14.09 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.58 | 29.51 | |
| Mar2025 | ₹1.22 | 22.00 | |
| Mar2024 | ₹1.00 | 14.94 | |
| Mar2023 | ₹0.87 | -70.00 | |
| Mar2022 | ₹2.90 | - | |
MEDICO REMEDIES Return on Capital Employed (ROCE)
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 7.53 % |
| 5 Yr CAGR | 11.45 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 23.28% | 7.53 | |
| Mar2025 | 21.65% | -1.14 | |
| Mar2024 | 21.9% | 0.09 | |
| Mar2023 | 21.88% | 45.00 | |
| Mar2022 | 15.09% | - | |
MEDICO REMEDIES Share Price vs Sensex
| Current Share Price | : | ₹21.9 |
| Current MarketCap | : | ₹ 181.9 Cr |
| Updated EOD on | : | Oct 16,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICO REMEDIES | -0.8% |
-38.3% |
-56% |
| SENSEX | 3.1% |
1% |
-9.1% |
MEDICO REMEDIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -1.2% | -4.4% | 9.1% |
No NSE index found
You may also like the below Video Courses
FAQ about MEDICO REMEDIES Financials
How the annual revenues of MEDICO REMEDIES have changed ?
The Revenues of MEDICO REMEDIES have increased by 36.73% YoY .
How the Earnings per Share (EPS) of MEDICO REMEDIES have changed?
The Earnings Per Share (EPS) of MEDICO REMEDIES has increased by 29.51 % YoY .
Check out Intrinsic Value of Peers of MEDICO REMEDIES
Compare Stock Analytics of Peers of MEDICO REMEDIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
